Citi upgrades Qinetiq to ‘buy’, shares rally

by | Dec 17, 2021

Qinetiq rallied on Friday after Citi lifted its stance on the shares to ‘buy’ from ‘neutral’.
The bank noted that Qinetiq has lost around £500m market cap following a £14.5m writedown on a complex project in its interim results.

“While we accept there remains significant risk for investors on both this contract and potentially the risk management process, we also believe that 1) this is more than priced in and 2) over the next 6-12 months, these risks are likely to be retired/subside, driving a rerating in the shares,” it said.

Citi said that it has assumed the write-down was a “one-off problem”, but also cut its price target on the shares to 340p from 370p and increased the risk rating to “high”.

At 1050 GMT, the shares were up 4.2% at 255.40p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x